Jefferies analyst Saree Boroditsky downgrades Generac Hldgs (NYSE:GNRC) from Hold to Underperform and lowers the price target from $95 to $85.
Caribou’s Blood Cancer Candidate Shows Response Rates Better Than Novartis,’ This Analyst Writes
Last week, Caribou Biosciences Inc (NASDAQ:CRBU) announced Q2 earnings and provided updated results from the Phase 1 ANTLER trial of the company’s…